Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D.

Warner K, See W, Haerry D, Klingmann I, Hunter A, May M.

Front Med (Lausanne). 2018 Oct 9;5:270. doi: 10.3389/fmed.2018.00270. eCollection 2018.

2.

Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.

Duijkers IJM, Klingmann I, Prinz R, Wargenau M, Hrafnsdottir S, Magnusdottir TB, Klipping C.

Hum Reprod. 2018 Nov 1;33(11):2131-2140. doi: 10.1093/humrep/dey288.

PMID:
30265306
3.

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials.

Klingmann I, Heckenberg A, Warner K, Haerry D, Hunter A, May M, See W.

Front Med (Lausanne). 2018 Sep 7;5:251. doi: 10.3389/fmed.2018.00251. eCollection 2018.

4.

EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment.

Hunter A, Facey K, Thomas V, Haerry D, Warner K, Klingmann I, May M, See W.

Front Med (Lausanne). 2018 Sep 6;5:231. doi: 10.3389/fmed.2018.00231. eCollection 2018.

5.

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes.

Haerry D, Landgraf C, Warner K, Hunter A, Klingmann I, May M, See W.

Front Med (Lausanne). 2018 Aug 17;5:230. doi: 10.3389/fmed.2018.00230. eCollection 2018.

6.

EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management.

Van Bortel L, Sourgens H, Breithaupt-Grögler K, Caplain H, Donazzolo Y, Klingmann I, Hammond M, Hardman TC, Stringer S, de Hoon J.

Front Pharmacol. 2018 Jan 17;8:901. doi: 10.3389/fphar.2017.00901. eCollection 2017.

7.

Question 1: How safe are ACE inhibitors for heart failure in children?

van der Meulen M, Dalinghaus M, Burch M, Szatmari A, Castro Diez C, Khalil F, Swoboda V, Breur J, Bajcetic M, Jovanovic I, Lagler FB, Klingmann I, Laeer S, de Wildt SN.

Arch Dis Child. 2018 Jan;103(1):106-109. doi: 10.1136/archdischild-2017-312774. Epub 2017 Oct 26. No abstract available.

PMID:
29074732
8.

Acute effects and after-effects of acoustic coordinated reset neuromodulation in patients with chronic subjective tinnitus.

Adamchic I, Toth T, Hauptmann C, Walger M, Langguth B, Klingmann I, Tass PA.

Neuroimage Clin. 2017 May 28;15:541-558. doi: 10.1016/j.nicl.2017.05.017. eCollection 2017.

9.

SPRINTT and the involvement of stakeholders: strategy and structure.

Le Lain R, Ignaszewski C, Klingmann I, Cesario A, de Boer WI; SPRINTT Consortium.

Aging Clin Exp Res. 2017 Feb;29(1):65-67. doi: 10.1007/s40520-016-0706-3. Epub 2017 Jan 31. Review.

PMID:
28144912
10.

The Good Clinical Practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa.

Vischer N, Pfeiffer C, Joller A, Klingmann I, Ka A, Kpormegbe SK, Burri C.

Trop Med Int Health. 2016 Aug;21(8):1040-1048. doi: 10.1111/tmi.12734. Epub 2016 Jun 28.

11.

Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for action.

Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:189-91. doi: 10.1016/j.ejogrb.2016.04.004. Epub 2016 Apr 9.

PMID:
27132709
12.

Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for action.

Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:211-4. doi: 10.1016/j.ejogrb.2016.04.016. Epub 2016 Apr 25. Review.

PMID:
27132708
13.

Corrigendum: Core competencies for pharmaceutical physicians and drug development scientists.

Silva H, Stonier P, Buhler F, Deslypere JP, Criscuolo D, Nell G, Massud J, Geary S, Schenk J, Kerpel-Fronius S, Koski G, Clemens N, Klingmann I, Kesselring G, van Olden R, Dubois D.

Front Pharmacol. 2015 Jan 15;5:297. doi: 10.3389/fphar.2014.00297. eCollection 2014.

14.

Securing the future of drug discovery for central nervous system disorders.

Andersen PH, Moscicki R, Sahakian B, Quirion R, Krishnan R, Race T, Phillips A; 2013 CINP Summit Group.

Nat Rev Drug Discov. 2014 Dec;13(12):871-2. doi: 10.1038/nrd4489.

PMID:
25435203
15.

ICH: Strengths, Weaknesses, and Future Tasks.

Specht S, Klingmann I.

Ther Innov Regul Sci. 2014 May;48(3):357-361. doi: 10.1177/2168479013520161.

PMID:
30235539
16.

Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial.

Münzel T, Meinertz T, Tebbe U, Schneider HT, Stalleicken D, Wargenau M, Gori T, Klingmann I; CLEOPATRA Study Investigators.

Eur Heart J. 2014 Apr;35(14):895-903. doi: 10.1093/eurheartj/eht384. Epub 2013 Sep 26.

17.

A European approach to clinical investigator training.

Boeynaems JM, Canivet C, Chan A, Clarke MJ, Cornu C, Daemen E, Demotes J, Nys KD, Hirst B, Hundt F, Kassai B, Kerpel-Fronius S, Kiessig L, Klech H, Kraehenbuhl JP, Lafolie P, Lucht M, Niese D, Pauli-Magnus C, Peters B, Schaltenbrand R, Stockis A, Stykova M, Verheus N, Klingmann I.

Front Pharmacol. 2013 Sep 9;4:112. doi: 10.3389/fphar.2013.00112. Review.

18.

Core competencies for pharmaceutical physicians and drug development scientists.

Silva H, Stonier P, Buhler F, Deslypere JP, Criscuolo D, Nell G, Massud J, Geary S, Schenk J, Kerpel-Fronius S, Koski G, Clemens N, Klingmann I, Kesselring G, van Olden R, Dubois D.

Front Pharmacol. 2013 Aug 26;4:105. doi: 10.3389/fphar.2013.00105. eCollection 2013. Erratum in: Front Pharmacol. 2014;5:297.

19.

Consensus standards for introductory e-learning courses in human participants research ethics.

Williams JR, Sprumont D, Hirtle M, Adebamowo C, Braunschweiger P, Bull S, Burri C, Czarkowski M, Fan CT, Franck C, Gefenas E, Geissbuhler A, Klingmann I, Kouyaté B, Kraehenbhul JP, Kruger M, Moodley K, Ntoumi F, Nyirenda T, Pym A, Silverman H, Tenorio S.

J Med Ethics. 2014 Jun;40(6):426-8. doi: 10.1136/medethics-2013-101572. Epub 2013 Aug 19.

20.

Has the European Clinical Trials Directive been a success?

Frewer LJ, Coles D, Champion K, Demotes-Mainard J, Goetbuget N, Ihrig K, Klingmann I, Kubiak C, Lejeune SA, McDonald F, Apperley J.

BMJ. 2010 Apr 9;340:c1862. doi: 10.1136/bmj.c1862. No abstract available.

PMID:
20382668

Supplemental Content

Loading ...
Support Center